GSK Statistics
Total Valuation
GSK plc has a market cap or net worth of $71.26 billion. The enterprise value is $86.54 billion.
Important Dates
The next confirmed earnings date is Wednesday, February 5, 2025, before market open.
| Earnings Date | Feb 5, 2025 |
| Ex-Dividend Date | Nov 15, 2024 |
Share Statistics
GSK plc has 4.08 billion shares outstanding. The number of shares has increased by 0.71% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 4.08B |
| Shares Change (YoY) | +0.71% |
| Shares Change (QoQ) | +0.46% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 3.94B |
Valuation Ratios
The trailing PE ratio is 21.17 and the forward PE ratio is 8.67.
| PE Ratio | 21.17 |
| Forward PE | 8.67 |
| PS Ratio | n/a |
| Forward PS | 2.21 |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 9.45 |
| P/OCF Ratio | 7.16 |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
The stock's EV/EBITDA ratio is 6.98, with an EV/FCF ratio of 11.48.
| EV / Earnings | 25.71 |
| EV / Sales | 2.06 |
| EV / EBITDA | 6.98 |
| EV / EBIT | 9.37 |
| EV / FCF | 11.48 |
Financial Position
The company has a current ratio of 0.81, with a Debt / Equity ratio of 1.19.
| Current Ratio | 0.81 |
| Quick Ratio | 0.52 |
| Debt / Equity | 1.19 |
| Debt / EBITDA | 1.70 |
| Debt / FCF | 2.85 |
| Interest Coverage | 10.83 |
Financial Efficiency
Return on equity (ROE) is 21.85% and return on invested capital (ROIC) is 13.67%.
| Return on Equity (ROE) | 21.85% |
| Return on Assets (ROA) | 7.24% |
| Return on Invested Capital (ROIC) | 13.67% |
| Return on Capital Employed (ROCE) | 18.82% |
| Revenue Per Employee | $597,707 |
| Profits Per Employee | $47,933 |
| Employee Count | 70,212 |
| Asset Turnover | 0.53 |
| Inventory Turnover | 1.52 |
Taxes
In the past 12 months, GSK plc has paid $596.43 million in taxes.
| Income Tax | 596.43M |
| Effective Tax Rate | 13.51% |
Stock Price Statistics
The stock price has decreased by -9.77% in the last 52 weeks. The beta is 0.33, so GSK plc's price volatility has been lower than the market average.
| Beta (5Y) | 0.33 |
| 52-Week Price Change | -9.77% |
| 50-Day Moving Average | 34.04 |
| 200-Day Moving Average | 38.99 |
| Relative Strength Index (RSI) | 60.18 |
| Average Volume (20 Days) | 4,190,130 |
Short Selling Information
| Short Interest | 17.89M |
| Short Previous Month | 18.41M |
| Short % of Shares Out | 0.88% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 4.87 |
Income Statement
In the last 12 months, GSK plc had revenue of $41.97 billion and earned $3.37 billion in profits. Earnings per share was $0.81.
| Revenue | 41.97B |
| Gross Profit | 30.38B |
| Operating Income | 9.23B |
| Pretax Income | 6.06B |
| Net Income | 3.37B |
| EBITDA | 12.41B |
| EBIT | 9.23B |
| Earnings Per Share (EPS) | $0.81 |
Full Income StatementBalance Sheet
The company has $4.31 billion in cash and $21.52 billion in debt, giving a net cash position of -$17.22 billion or -$4.22 per share.
| Cash & Cash Equivalents | 4.31B |
| Total Debt | 21.52B |
| Net Cash | -17.22B |
| Net Cash Per Share | -$4.22 |
| Equity (Book Value) | 18.03B |
| Book Value Per Share | 4.60 |
| Working Capital | -5.58B |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $9.95 billion and capital expenditures -$1.80 billion, giving a free cash flow of $7.54 billion.
| Operating Cash Flow | 9.95B |
| Capital Expenditures | -1.80B |
| Free Cash Flow | 7.54B |
| FCF Per Share | $1.85 |
Full Cash Flow StatementMargins
Gross margin is 72.39%, with operating and profit margins of 22.00% and 8.02%.
| Gross Margin | 72.39% |
| Operating Margin | 22.00% |
| Pretax Margin | 10.52% |
| Profit Margin | 8.02% |
| EBITDA Margin | 29.56% |
| EBIT Margin | 22.00% |
| FCF Margin | 17.97% |
Dividends & Yields
This stock pays an annual dividend of $1.56, which amounts to a dividend yield of 4.41%.
| Dividend Per Share | $1.56 |
| Dividend Yield | 4.41% |
| Dividend Growth (YoY) | 12.10% |
| Years of Dividend Growth | 1 |
| Payout Ratio | 191.09% |
| Buyback Yield | -0.71% |
| Shareholder Yield | 3.70% |
| Earnings Yield | 4.72% |
| FCF Yield | 10.58% |
Dividend DetailsAnalyst Forecast
The average price target for GSK plc is $47.00, which is 33.26% higher than the current price. The consensus rating is "Hold".
| Price Target | $47.00 |
| Price Target Difference | 33.26% |
| Analyst Consensus | Hold |
| Analyst Count | 4 |
| Revenue Growth Forecast (5Y) | 3.60% |
| EPS Growth Forecast (5Y) | 9.17% |
Stock ForecastsStock Splits
The last stock split was on July 19, 2022. It was a reverse split with a ratio of 0.8:1.
| Last Split Date | Jul 19, 2022 |
| Split Type | Reverse |
| Split Ratio | 0.8:1 |
Scores
GSK plc has an Altman Z-Score of 1.91 and a Piotroski F-Score of 7. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.91 |
| Piotroski F-Score | 7 |